The mIRD [ICMR-recommended rapid molecular screening cum diagnostic test will be offered to all eligible clients in this study arm. The mIRD that will be used in the study is Quantiplus® MTB FAST Detection Kit PI/QLFMTB-03. The sputum samples or tongue swab (when not able to produce sputum) specimen collected from all the eligible population will be subjected to mIRD. Clients who have symptoms suggestive of TB or mIRD positive for MTB will be considered presumptive TB and offered NAAT MTB assay for detecting bacteriologically-confirmed TB.
